Radnet, INC 8-K filings

RadNet, Inc. has filed a prospectus supplement to register for resale up to 34,069 shares of its common stock by certain See-Mode Sellers, stemming from a June 2025 Share Purchase Agreement.

RadNet, Inc. announced record-breaking second quarter financial results for 2026, driven by significant revenue growth and adjusted EBITDA, leading to an upward revision of full-year financial guidance.

RadNet, Inc. has entered into an incremental amendment to its credit agreement, securing $250 million in new term loans while reducing interest rates on its credit facilities by 0.25%.

RadNet, Inc. announced its intention to secure a $200 million incremental term loan to fund strategic growth opportunities including acquisitions and expansion.

RadNet announced record first-quarter 2026 financial results, exceeding prior year performance and leading to upward revisions in full-year guidance for revenue, Adjusted EBITDA, and Free Cash Flow.

RadNet, Inc. reported record fourth-quarter 2025 revenue and Adjusted EBITDA, driven by strong procedural growth and strategic AI investments, while issuing robust 2026 financial guidance.

RadNet's DeepHealth subsidiary acquired French AI radiology firm Gleamer for up to €230 million, creating the world's largest provider of clinical AI solutions.

RadNet, Inc. filed a prospectus supplement to register 190,924 common shares for resale by sellers involved in its November 2025 acquisition of Cimar (UK) Limited.

RadNet, Inc. announced the promotion of four senior leaders to expanded executive roles and approved salary adjustments for key management, effective January 2026.

RadNet, Inc. filed a prospectus supplement to register 73,567 common shares for resale by selling stockholders, stemming from prior acquisitions.

RadNet, Inc. reported record third-quarter revenue and Adjusted EBITDA, leading to an upward revision of its full-year 2025 financial guidance.

RadNet, Inc. filed a prospectus supplement to register 59,444 shares of common stock for resale by selling stockholders, stemming from an asset purchase agreement.

RadNet, Inc. announced record second-quarter 2025 financial results, including significant revenue and Adjusted EBITDA growth, leading to an upward revision of its full-year 2025 financial guidance.

RadNet, Inc., through its DeepHealth subsidiary, has finalized the acquisition of iCAD, Inc., significantly expanding its AI capabilities and global reach in breast cancer screening and diagnosis.

RadNet, Inc. has successfully secured a new $100 million incremental term loan to fund future acquisitions and general corporate purposes, while also announcing the approval of all proposals at its 2025 Annual Meeting of Stockholders.

RadNet's first quarter 2025 financial results were impacted by weather-related events, but the company revised its full-year guidance upwards for revenue and adjusted EBITDA.

RadNet, Inc. will acquire iCAD, Inc. in an all-stock transaction valued at approximately $103 million to enhance AI-powered early detection and diagnosis of breast cancer.

RadNet announces record fourth-quarter 2024 results with a 13.5% increase in total company revenue and a 14.0% increase in Adjusted EBITDA, while also releasing its 2025 financial guidance.

RadNet has successfully amended its credit facility, resulting in a 0.25% reduction in interest rates on its term loans and revolving credit facility.

RadNet announced record third-quarter revenue and adjusted EBITDA, driven by strong growth in both its imaging center and digital health segments, leading to an upward revision of its full-year 2024 financial guidance.

RadNet highlights its digital health segment's growth, driven by AI solutions and a new cloud-based platform, at a Jefferies investor call.

RadNet has appointed Kees Wesdorp, a seasoned healthcare executive, as President and CEO of its Digital Health division, effective October 1, 2024.

RadNet reported record quarterly revenue and adjusted EBITDA in the second quarter of 2024, driven by strong performance in both its imaging center and digital health segments, leading to an upward revision of its full-year 2024 financial guidance.

RadNet, Inc. held its 2024 Annual Meeting of Stockholders on June 12, 2024, where stockholders voted on the election of directors, ratification of the company's accounting firm, and executive compensation.

RadNet achieved record first-quarter revenue, adjusted EBITDA, and adjusted earnings, driven by strong performance in both its imaging center and digital health segments, leading to an upward revision of its 2024 financial guidance.

RadNet successfully closed a refinancing transaction, securing an $875 million term loan and a $282 million revolving credit facility.

RadNet successfully priced and upsized its refinancing transaction, securing a new $875 million term loan and $282 million revolving credit facility, while also adding $180 million to its balance sheet.

RadNet is seeking to refinance its existing debt facilities with a new term loan and revolving credit facility to extend maturities, lower cost of capital, and raise additional funds.

RadNet successfully closed a public offering of common stock, raising approximately $230.2 million for general corporate purposes and potential acquisitions.

RadNet achieved record revenue and adjusted EBITDA in the fourth quarter of 2023, driven by strong industry trends and strategic growth initiatives, and has introduced a new Digital Health reporting segment.